Use of SGLT2 inhibitors in real life: predicting left ventricular reverse remodelling.

13 May 2024 (13:34 - 14:42)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Vincenzo De Simone

Mater Salutis Hospital, Legnago (Italy)

6 More presentations in this session

Presentation thumbnail

Challenging the norm: the use of sublingual nitroglycerin in patients with severe aortic stenosis undergoing cardiac CT

Doctor A. Silva (Coimbra, PT)

Abstract Slides Video

Presentation thumbnail

Age differences in prescribing guideline-directed medical treatment in heart failure with mildly reduced and reduced ejection fraction

Doctor V. Lopes (Coimbra, PT)

Abstract Slides Video

Presentation thumbnail

Adherence to the guideline-directed medical therapy in chronic heart failure: insight from a University Hospital

Doctor M. Assamti (Oujda, MA)

Abstract Slides Video

Presentation thumbnail

Prescribing SGLT2 inhibitors in acute heart failure: considerations for dysglycemia status, heart failure phenotype, and kidney function

Doctor A. Amanova (Aktobe, KZ)

Abstract Slides Video

Presentation thumbnail

Real world registry of use of SGLT2i in patients with HFrEF followed in a non-tertiary hospital.

Mr V. Martinez Mateo (Alcazar de San Juan, ES)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in interventional cardiology and pharmacology 2

The Event

Event poster

Heart Failure 2024

13 May 2024 13:34 CET

You may be interested in

Congress Presentation

Cardiac reverse remodeling and SGLT2ii: insight from hemodynamic forces analysis

Congress Presentation

Cardiac reverse remodeling after SGLT2 inhibitor therapy: exploring beyond sex differences

Congress Presentation

The impact of sodium glucose transporter 2 inhibitors on cardiac remodeling in a large cohort of unselected patients

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources